Treatment of patients with low-risk myelodysplastic syndromes using a combination of all- trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor
1999; Springer Science+Business Media; Volume: 78; Issue: 3 Linguagem: Inglês
10.1007/s002770050488
ISSN1432-0584
AutoresW.-K. Hofmann, Arnold Ganser, G. Seipelt, Oliver G. Ottmann, C. Zander, G Geissler, Kristina Hoffmann, K. Höffken, J.-Th. Fischer, G. Isele, D. Hoelzer,
Tópico(s)Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Referência(s)